Acyclovir Capsule
Product Images NDC 61442-114

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 61442-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carlsbad Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Principal Display Panel (6144211401)

Package Label – Principal Display Panel (6144211401)
Acyclovir Capsules USP are a medication used for treating infections caused by the herpes virus such as genital herpes, cold sores, and shingles. Each capsule of Acyclovir contains 200 mg of the active ingredient. The usual dosage and full prescribing information can be found in the package insert. The medication should be kept in a tight container at a temperature of 20° to 25°C (68° to 77°F) and protected from light and moisture. Acyclovir Capsules USP are available in a pack of 100 units and can only be obtained with a prescription. The product is manufactured and distributed by Carlsbad Tech located at 5928 Farnsworth Court, Carlsbad, CA92008, USA.*
FDA Label Image

Package Label – Principal Display Panel (6144211405)

Package Label – Principal Display Panel (6144211405)
The text gives information about Acyclovir USP, which is present in 200mg in each capsule. The standard dosage should be checked from the package insert. The capsules should be stored in a tight container away from light and moisture at a controlled room temperature of 20°-25°C (68°-77°F), as defined in the USP. The capsules have been manufactured and distributed by Carlsbad Tech and come in a pack of 500 capsules. The text also provides a product code (NDC) and a revision date for the related package insert.*
FDA Label Image

Structural Formula (Acy03 0000 01)

FDA Label Image

Table 1 (Acy03 0000 02)

Table 1 (Acy03 0000 02)
This is a table showing the pharmacokinetic characteristics of Acyclovir. The table mentions the range for parameters like plasma protein binding, plasma elimination half-life and average oral bioavailability for the drug. It also notes that the bioavailability of the drug decreases with increasing dose.*
FDA Label Image

Table 2 (Acy03 0000 03)

Table 2 (Acy03 0000 03)
This text presents a table that shows the Acyclovir peak and rough concentrations at steady-state for three different doses (200mg, 400mg, and 800mg). The table includes values for Cmax and Ctrough for each dosage strength.*
FDA Label Image

Table 3 (Acy03 0000 04)

Table 3 (Acy03 0000 04)
Table 3 shows the dosage modification for patients with renal impairment for a particular medication. The table lists the normal dosage, creatinine clearance levels, and adjusted dosage regimens in terms of dose and dosing intervals. The dosage regimens are adjusted based on the patient's renal function, with lower doses and longer dosing intervals for those with impaired renal function. The medication is available in 200mg, 400mg, and 800mg doses, to be taken every 4, 8, or 12 hours depending on the adjusted dosage regimen.*
FDA Label Image

Imprint Cti 114 (Acy03 0000 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.